arGEN-X Aktie

619,40EUR -3,00EUR -0,48%
arGEN-X für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A11602 / ISIN: NL0010832176

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 336 650 843 1 148 1 599
Umsatz pro Mitarbeiter in Mio. EUR 0,11 0,65 0,46 0,99 1,27

Bilanz (in Mio. EUR) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 1 676 2 236 2 599 3 733 4 716
Summe Anlagevermögen 181 270 337 379 1 274
Summe Aktiva 1 858 2 506 2 937 4 112 5 990

Bilanz (in Mio. EUR) - Passiva

2020 2021 2022 2023 2024
Summe Fremdkapital 493 278 300 403 680
Summe Eigenkapital 1 364 2 228 2 636 3 709 5 310
Summe Passiva 1 858 2 506 2 937 4 112 5 990

Adresse

Laarderhoogtweg 25, 1101 EB Amsterdam
Telefon +31 (76) 303-04-88
Internet http://www.argen-x.com

Management

Ana Cespedes
Independent Non-Executive Director
Anthony Adam Rosenberg
Independent Non-Executive Director
Arjen Lemmen
Vice President-Corporate Development & Strategy
Beth Delgiacco
VP-Corporate Communications & Investor Relations
Brian L. Kotzin
Non-Executive Director
Camilla Sylvest
Independent Non-Executive Director
Filip Borgions
Chief Technology Innovation Officer
Hemamalini Moorthy
General Counsel
James M. Daly
Independent Non-Executive Director
Joseph Donald deBethizy
Vice Chairman
Karen Massey
Chief Operating Officer
Karl Gubitz
Chief Financial Officer
Luc Truyen
Chief Medical Officer
Marc Schorpion
Global Head-Human Resources
Pamela M. Klein
Independent Non-Executive Director
Peter K. M. Verhaeghe
Non-Executive Chairman
Peter Ulrichts
Chief Scientific Officer
Steve E. Krognes
Independent Non-Executive Director
Tim van Hauwermeiren
Chief Executive Officer & Executive Director